An interventional study of completion of questionnaire in Food Allergy in Children and 6 Years Old Maximum, sponsored by University Hospital, Angers. Completed at 1 site in France. Open to participants aged 6 Months to 6 Years. Per ClinicalTrials.gov, last updated 2023-09-22.
Sponsored by University Hospital, Angers · Not applicable, Interventional, and Supportive care
Orality disorders are frequent in child. There are complications like growth and psychomotor development disorders.
The aim is to estimate the prevalence of orality disorder for child with one or several food allergy.
1,916 studies on the registry are indexed under Hypersensitivity; 265 are open to participants now.
This study's enrollment of 150 is above the median of 57 across 1,384 interventional studies indexed under Hypersensitivity.
Browse Hypersensitivity studies →University Hospital, Angers is the lead sponsor of 464 studies on the registry; 116 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
oral disorder
Other: completion of questionnaire
parents have to complete 2 questionnaires: demographic questionnaire and Montréal questionnaire when they come on allergy consultation.
Prevalence of orality disorder in children with food allergy
Time frame: Enrollment
Link between orality disorder and number of excluded food, time from excluded regimen, age of the beginning of diet diversification, breastfeeding and duration,status of the child in the family and demographic data.
All data will be collected by a questionnaire established by Angers Hospital
Time frame: Enrollment
Link between food allergies and orality disorder
data will be collected by a questionnaire
Time frame: Enrollment
Prevalence of dysphagia criteria
Time frame: Enrollment
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Angers